Sangamo Announces Capsid License Agreement with Lilly to Delivery Genomic Medicines for Diseases of the Central Nervous System

Click here to view

Presentation

Poster: Epigenetic Regulation of Human Prion Expression as a Potential One-Time Treatment for Prion Disease

Download PDF